Bayer

Company snapshot

Bayer is a pharma organization headquartered in WATERFALL CITY MIDRAND, ZA. NovaPharmaNews links 0 clinical program(s), 0 drug profile(s), and 0 patent record(s) to this entity from public FDA, EMA, ClinicalTrials.gov, and USPTO sources.

• 25 US patent(s) indexed to this assignee profile.

Public regulatory, clinical, patent, and corporate records for Bayer. Not investment advice.

• approval Jun 1, 2026

  Bayer's $300M Acquisition: A Strategic Move in Ophthalmology

Recent activity

Latest pipeline, patent, and corporate events for Bayer.

1. Jun 1, 2026 Partnership signal

   Bayer's $300M Acquisition: A Strategic Move in Ophthalmology

2. May 28, 2026 Patent grant

   TECHNOLOGIE DE PLATEFORME DE GRANULATION PAR VOIE HUMIDE POUR FABRIQUER DES COMPRIMÉS/ARTICLES À MÂCHER MOUS

3. May 21, 2026 Patent grant

   FORMULATIONS ET PROCÉDÉS POUR MAINTENIR UNE SUSPENSION ET UNE VIABILITÉ DE CELLULES

4. May 13, 2026 Patent grant

   MULTIMERE MANGANKONTRASTMITTEL

5. Apr 2, 2026 Patent grant

   PROCESSUS DE NANOENSEMENCEMENT AMÉLIORÉ

View all clinical trial activity →

• What is Bayer?

  Bayer is a pharma organization headquartered in WATERFALL CITY MIDRAND, ZA. NovaPharmaNews links 0 clinical program(s), 0 drug profile(s), and 0 patent record(s) to this entity from public FDA, EMA, ClinicalTrials.gov, and USPTO sources.

• Is Bayer publicly traded?

  Bayer appears in our database through regulatory marketing authorisation or clinical trial sponsor records; a US listed ticker is not shown for this entity.

• What drugs does Bayer develop or market?

  No drug profiles are currently linked to Bayer. Pipeline programs may still list investigational assets.

• What are the latest developments for Bayer?

  Browse related news and pipeline sections on this page for coverage and ClinicalTrials.gov-linked program updates.

• What therapeutic areas does Bayer focus on?

  No specific therapeutic focus areas are currently identified for Bayer in our database.